Quick Answer
Vicapsys Life Sciences, Inc. reported Total Assets of $39.7 thousand for fiscal year 2023.
Vicapsys Life Sciences, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2023 | $39.7K | -44.9% |
| 2022 | $72.0K | -87.9% |
| 2021 | $594.3K | +47.1% |
| 2020 | $404.1K | -42.1% |
| 2019 | $698.4K | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2024 | $89.6K | -57.0% | +125.9% |
| December 31, 2023 | $39.7K | -44.9% | -81.0% |
| September 30, 2023 | $208.5K | -45.7% | -44.9% |
| June 30, 2023 | $378.1K | -1.1% | +497.5% |
| March 31, 2023 | $63.3K | -86.8% | -12.1% |
| December 31, 2022 | $72.0K | -87.9% | -81.2% |
| September 30, 2022 | $383.8K | -30.5% | +0.4% |
| June 30, 2022 | $382.2K | -32.0% | -20.1% |
- Vicapsys Life Sciences, Inc. showed a decrease of -44.9% in Total Assets compared to the prior fiscal year.
- Over the 2019–2023 period, Vicapsys Life Sciences, Inc.’s total assets has declined by 94.3% (from $698.4 thousand to $39.7 thousand).
- The most recent figure is from Vicapsys Life Sciences, Inc.’s fiscal year 2023 report (Form 10-K), filed with the SEC on October 21, 2024.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: